跳至主要内容
临床试验/NCT01137032
NCT01137032已完成4 期

An Open -Label Study to Evaluate the Effect of Pandel Cream 0.1% on the Hypothalamic Pituitary Adrenal Axis in the Pediatric and Adult Population

Fougera Pharmaceuticals Inc.3 个研究点 分布在 1 个国家目标入组 19 人开始时间: 2004年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
19
试验地点
3
主要终点
Post-injection Serum Cortisol Level

研究概览

简要总结

The purpose of this study is to determine the effect of Pandel® (hydrocortisone probutate cream) Cream 0.1% on the Hypothalamic Pituitary Adrenal (HPA) axis in pediatric and adult subjects with either psoriasis or atopic dermatitis involving greater than 20% body surface area.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
3 Months 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of psoriasis or atopic dermatitis involving more than 20% of body surface area
  • Good health with the exception of psoriasis or atopic dermatitis

排除标准

  • Any disease affecting the HPA-axis
  • Subjects who are pregnant, nursing, or planning a pregnancy within the study participation period

研究组 & 干预措施

Pandel Cream 0.1%

Experimental

Pandel Cream 0.1%

干预措施: Pandel Cream 0.1% (Drug)

结局指标

主要结局

Post-injection Serum Cortisol Level

时间窗: 22 Days

The number of subjects with a post-injection serum cortisol level less than or equal to 18 ug/dL on Day 22.

次要结局

  • and the Number of Subjects With an Increment Between Basal and 30 Minutes Day 22 of at Least 7 ug/dL.(22 days)
  • Pre-injection Serum Cortisol Levels(22 Days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验